Voxel S.A. (VOX) - Net Assets
Based on the latest financial reports, Voxel S.A. (VOX) has net assets worth zł415.63 Million PLN (≈ $114.39 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł706.69 Million ≈ $194.49 Million USD) and total liabilities (zł291.06 Million ≈ $80.10 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Voxel S.A. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł415.63 Million |
| % of Total Assets | 58.81% |
| Annual Growth Rate | 12.36% |
| 5-Year Change | 80.29% |
| 10-Year Change | 257.13% |
| Growth Volatility | 9.85 |
Voxel S.A. - Net Assets Trend (2010–2025)
This chart illustrates how Voxel S.A.'s net assets have evolved over time, based on quarterly financial data. See Voxel S.A. (VOX) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Voxel S.A. (2010–2025)
The table below shows the annual net assets of Voxel S.A. from 2010 to 2025. For live valuation and market cap data, see market cap of Voxel S.A..
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | zł415.63 Million ≈ $114.39 Million |
+13.36% |
| 2024-12-31 | zł366.64 Million ≈ $100.90 Million |
+24.11% |
| 2023-12-31 | zł295.41 Million ≈ $81.30 Million |
+21.11% |
| 2022-12-31 | zł243.91 Million ≈ $67.13 Million |
+5.81% |
| 2021-12-31 | zł230.53 Million ≈ $63.44 Million |
+27.24% |
| 2020-12-31 | zł181.17 Million ≈ $49.86 Million |
+16.31% |
| 2019-12-31 | zł155.77 Million ≈ $42.87 Million |
+8.74% |
| 2018-12-31 | zł143.25 Million ≈ $39.43 Million |
+9.81% |
| 2017-12-31 | zł130.46 Million ≈ $35.90 Million |
+12.10% |
| 2016-12-31 | zł116.38 Million ≈ $32.03 Million |
+4.71% |
| 2015-12-31 | zł111.15 Million ≈ $30.59 Million |
+7.43% |
| 2014-12-31 | zł103.47 Million ≈ $28.48 Million |
-4.98% |
| 2013-12-31 | zł108.89 Million ≈ $29.97 Million |
+31.76% |
| 2012-12-31 | zł82.64 Million ≈ $22.74 Million |
-0.89% |
| 2011-12-31 | zł83.39 Million ≈ $22.95 Million |
+15.24% |
| 2010-12-31 | zł72.36 Million ≈ $19.92 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Voxel S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 30991517505.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł309.54 Million | 75.70% |
| Other Components | zł99.36 Million | 24.30% |
| Total Equity | zł408.90 Million | 100.00% |
Voxel S.A. Competitors by Market Cap
The table below lists competitors of Voxel S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LTC Co.Ltd
KQ:170920
|
$341.13 Million |
|
Bharat Bijlee Limited
NSE:BBL
|
$341.18 Million |
|
Diamond Food Indonesia PT
JK:DMND
|
$341.21 Million |
|
Nanjing Toua Hardware&Tools Co.Ltd.
SHE:301125
|
$341.23 Million |
|
Waskita Karya Persero Tbk
JK:WSKT
|
$340.97 Million |
|
Guangdong New Grand Long Packing Co Ltd
SHE:002836
|
$340.86 Million |
|
Zhejiang Baida Precision Mnfg
SHG:603331
|
$340.82 Million |
|
Hunan Xiangjia Animal Husbandry Co
SHE:002982
|
$340.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Voxel S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 360,569,200 to 408,900,700, a change of 48,331,500 (13.4%).
- Net income of 98,533,900 contributed positively to equity growth.
- Dividend payments of 47,720,700 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł98.53 Million | +24.1% |
| Dividends Paid | zł47.72 Million | -11.67% |
| Other Changes | zł-2.48 Million | -0.61% |
| Total Change | zł- | 13.40% |
Book Value vs Market Value Analysis
This analysis compares Voxel S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.03x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.83x to 3.03x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | zł7.96 | zł118.00 | x |
| 2011-12-31 | zł9.32 | zł118.00 | x |
| 2012-12-31 | zł8.34 | zł118.00 | x |
| 2013-12-31 | zł10.37 | zł118.00 | x |
| 2014-12-31 | zł9.85 | zł118.00 | x |
| 2015-12-31 | zł10.57 | zł118.00 | x |
| 2016-12-31 | zł11.07 | zł118.00 | x |
| 2017-12-31 | zł12.41 | zł118.00 | x |
| 2018-12-31 | zł13.63 | zł118.00 | x |
| 2019-12-31 | zł14.83 | zł118.00 | x |
| 2020-12-31 | zł17.12 | zł118.00 | x |
| 2021-12-31 | zł21.80 | zł118.00 | x |
| 2022-12-31 | zł23.03 | zł118.00 | x |
| 2023-12-31 | zł27.93 | zł118.00 | x |
| 2024-12-31 | zł34.33 | zł118.00 | x |
| 2025-12-31 | zł38.93 | zł118.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Voxel S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 24.10%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.88%
- • Asset Turnover: 0.83x
- • Equity Multiplier: 1.73x
- Recent ROE (24.10%) is above the historical average (13.45%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 3.58% | 4.19% | 0.36x | 2.39x | zł-4.62 Million |
| 2011 | -4.62% | -3.94% | 0.48x | 2.45x | zł-12.13 Million |
| 2012 | 3.88% | 5.55% | 0.34x | 2.03x | zł-5.06 Million |
| 2013 | 2.79% | 2.92% | 0.48x | 1.99x | zł-7.81 Million |
| 2014 | -3.31% | -3.33% | 0.48x | 2.08x | zł-13.77 Million |
| 2015 | 12.91% | 10.86% | 0.62x | 1.91x | zł3.23 Million |
| 2016 | 9.46% | 9.12% | 0.54x | 1.92x | zł-623.73K |
| 2017 | 15.20% | 13.01% | 0.64x | 1.83x | zł6.77 Million |
| 2018 | 16.33% | 13.72% | 0.60x | 1.97x | zł9.06 Million |
| 2019 | 14.75% | 10.85% | 0.63x | 2.17x | zł7.40 Million |
| 2020 | 18.88% | 10.37% | 0.75x | 2.44x | zł15.98 Million |
| 2021 | 30.81% | 15.94% | 0.89x | 2.16x | zł47.65 Million |
| 2022 | 18.37% | 10.71% | 0.89x | 1.93x | zł20.24 Million |
| 2023 | 25.30% | 17.49% | 0.80x | 1.80x | zł44.87 Million |
| 2024 | 26.75% | 19.00% | 0.79x | 1.77x | zł60.40 Million |
| 2025 | 24.10% | 16.88% | 0.83x | 1.73x | zł57.64 Million |
Industry Comparison
This section compares Voxel S.A.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $115,087,414
- Average return on equity (ROE) among peers: -0.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Voxel S.A. (VOX) | zł415.63 Million | 3.58% | 0.70x | $341.08 Million |
| Biomaxima (BMX) | $16.83 Million | 7.29% | 0.39x | $10.99 Million |
| Scope Fluidics SA (SCP) | $6.70 Million | -9.52% | 0.41x | $91.68 Million |
| Selvita S.A. (SLV) | $321.73 Million | 0.25% | 0.86x | $156.57 Million |
About Voxel S.A.
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.